ALGS vs MKC · rev $3.6M vs P/E 8.4, $13.56B cap
Aligos Therapeutics Inc (ALGS) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
MKC does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the ALGS and MKC stock pages for the full models.
Not investment advice.